Skip to content
Screener

Rogers Corporation ROG Net Change in Cash

Net Change in Cash at other companies

3M logo
3MMMM
-$774M+70.4%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$11.73M
Biogen logo
BiogenBIIB
-$2.09B-2,371%
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
$138.82M+1,134%
DuPont de Nemours, Inc. logo
DuPont de Nemours, Inc.DD
-$7M+92.1%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$37.44M-41.4%

Other financials

Income statement

See full
Revenue$216.8M+6.9%
Gross profit$70.4M+10.0%
Operating income$20.0M+130%
Net income$13.6M+118%
EPS (diluted)$0.76+119%

Balance sheet

See full
Cash & equivalents$181.4M+15.4%
Total debt$28.5M-14.2%
Total equity$1.2B-0.2%
Total assets$1.4B-0.3%

Cash flow

See full
Operating cash flow$24.4M+78.1%
CapEx$6.1M-24.7%
Free cash flow$18.3M+227%

Valuation

See full
Market cap$2.39B+87.0%
Enterprise value$2.24B+93.9%
P/E89.5×
P/S2.9×+1.3×

Profitability

See full
Gross margin32.4%+0.2pp
Operating margin8.1%-6.7pp
Net margin3.2%+1.9pp
FCF margin9.9%+3.5pp

Returns & leverage

See full
Return on equity2.2%+1.3pp
Debt / equity0.0×
Current ratio+0.2×

Where this comes from

Reported directly by Rogers Corporation in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The source filing: Rogers Corporation’s 10-Q, filed July 29, 2026.

Filed
Jul 28, 2026, 8:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000084748-26-000048
Line itemSix Months Ended / June 30, 2026Six Months Ended / June 30, 2025
Share repurchases(3.0)(28.1)
Net cash used in financing activities(4.6)(29.6)
Effect of exchange rate fluctuations on cash(0.9)5.0
Net decrease in cash and cash equivalents(15.6)(2.6)
Cash and cash equivalents at beginning of period197.0159.8
Cash and cash equivalents at end of period$181.4$157.2
Supplemental Disclosures:
Accrued capital additions$3.1$3.9

Item 1. Condensed Consolidated Financial Statements (Unaudited):

FAQ

What is Rogers Corporation's net change in cash?
Rogers Corporation (ROG) reported net change in cash of -$14.4M in Q2 2026.
How has Rogers Corporation's net change in cash changed year-over-year?
Rogers Corporation's net change in cash increased by 21.7% year-over-year, from -$18.4M to -$14.4M.
What is the long-term trend for Rogers Corporation's net change in cash?
Over 3 years (2021 to 2025), Rogers Corporation's net change in cash has grown at a -2.8% compound annual growth rate (CAGR), from $40.51M to $37.2M.
What does net change in cash mean?
Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Ask your AI about Rogers Corporation's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude